Glycomics and Glycobiology Market is Segmented By Product(Enzymes, Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Other Enzymes (Carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases, and sulfatases)), Instruments, Mass Spectrometry Instruments, Chromatography Instruments, Arrays, Other Instruments (electrophoresis instruments, NMR instruments, and HPLC columns), Kits, Glycan Releasing Kits, Glycan Labeling Kits, Glycan Purification Kits, Other Kits (glycan detection kits, glycan enrichment kits, and glycan sample preparation kits), Carbohydrates, Oligosaccharides, Monosaccharides, Other Carbohydrates (rare sugars, glycoproteins, glycolipids, and glycol peptides), Reagents & Chemicals), By Application (Drug Discovery & Development, Disease Diagnostics, Other Applications (virology, cell biology, and microbiology)), By End-User( Hospitals, Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories) By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Glycomics and Glycobiology Market Size, Share, Trends, and Growth Insights
Glycomics and Glycobiology Market is Expected to reach a high CAGR 17.3% during the forecasting period (2024 - 2031). Glycomics or Glycobiology is the study of the structure, biology, and function of saccharides which are widely distributed in nature and regarded as glycans. Glycans are found in all living organisms. Glycobiology is a rapidly progressing biological area of interest for various fields like biotechnology, biomedicine, and basic research. Glycomics is a widely emerging scientific field highlighting defining functional aspects of glycans in biosystems.
Glycomics and Glycobiology Market Scope
Metrics |
Details |
Market CAGR |
17.3% |
Segments Covered |
By Product, By Application, By End-User, and By Region |
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
Fastest Growing Region |
Asia Pacific |
Largest Market Share |
North America |
Glycomics and Glycobiology Market Dynamics
The Glycomics and Glycobiology Market growth is driven by the increasing research activities on glycomics, rising R&D investments in pharmaceutical and biotechnology companies, and growth in the proteomics market.
The rising number of government's initiatives to increase funding for R&D is expected to drive growth in the forecast period
Increasing drug discovery and development is leading to a rise in R&D investments by biotech companies. Thus, the need for glycomics research techniques for conducting comprehensive glycomes studies is constantly increasing. The increase in the government's number of initiatives to increase funding for R&D has led to the increased need for glycomics techniques. The Australian government invested around USD 10.4 billion in scientific research activities and innovations for 2017-2018. The Irish Government also announced a USD 5.6 billion spending program in 2015, which aimed to increase the number of scientific research activities from 25,000 to 40,000.
Such funding initiatives are expected to propel the demand for glycomics research techniques in the near future. Key companies are also undertaking extensive R&D initiatives to develop new and technologically advanced products. For instance, in 2018, Shimadzu Corp. collaborated with PREMIER Biosoft, a global company in the field of bioinformatics solutions, with an aim to introduce its LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry system for advanced glycomics and lipidomics data research analysis. In addition, in 2016, ProZyme, Inc. launched Gly-Q Glycan Analysis System, an integrated platform that enables user-friendly and high-throughput glycoanalysis.
The high cost of tools is likely to hamper the market growth
The high cost of tools like Glycan Array Kit cost around $1,201.79 - $1,916.32 is expected to hamper the market growth.
Glycomics and Glycobiology Market Industry Analysis
PEST Analysis
Opportunities
COVID-19 Impact Analysis
Pharmaceutical and biotech companies, together with governments around the globe, are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the need for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness significant growth in the future.
Glycomics and Glycobiology Market Segment Analysis
The mass spectrometry instruments segment is expected to hold the largest share in this market segment
Mass spectrometry instruments are the largest and the fastest-growing product segment in the market, majorly due to the high advantages. Mass Spectrometry (MS) has been recognized as a valuable technique for quantifying proteins in the clinical chemistry laboratory. The advantage of MS is its increased analytical specificity over conventional detection methods. MS-based methods allow for the unequivocal identification of glycans, peptides, and glycopeptides through the unique combination of precursor mass and fragmentation patterns. As such, the technique allows for the molecular characterization of proteins (the proteoforms), including the presence of specific glycoforms. The measurand of a test can, thus, be defined much more accurately using MS, as compared to using activity- or immunoassays, that are typically ‘blind’ to the individual proteins.
Moreover, MS is widely used in free oligosaccharides, glycosaminoglycans, and the glycan portions of glycoproteins, proteoglycans, and glycolipids. And there is a wide range of MS techniques available for glycomics analysis. For instance, On June 4, 2018, Shimadzu Corp. and PREMIER Biosoft introduced its LCMS-9030 Quadruple Time of Flight (Q-TOF) mass spectrometry system.
Glycomics and Glycobiology Market Geographical Analysis
North America is expected to dominate the global market, followed by Europe. The largest share of North America is mainly attributed to increasing product launches in glycan analysis systems. For instance, on November 15, 2016, ProZyme, Inc. launched Gly-Q Glycan Analysis System which is an integrated platform that is a user-friendly glycoanalysis. Furthermore, the US government spends a significant percentage of its GDP on R&D. According to a 2018 report published by the Organization for Economic Co-operation and Development (OECD), about 2.82% of the country’s GDP was spent on R&D. In addition, in 2019, the research and development (R&D) expenditure of the US pharmaceutical industry was around USD 83 billion up from USD 79.6 billion in 2018 and USD 71.4 billion in 2017. Thus, increasing R&D activities increase the demand for mass spectrometers and drive market growth.
Glycomics and Glycobiology Market Competitive Landscape
The global Glycomics and Glycobiology Market is highly competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Merck KGaA, Agilent Technologies, Thermo Fisher Scientific, New England Biolabs, Shimadzu Corporation, Waters Corporation, Asparia Glycomics S.L, Bruker Corporation, Chemily Glycoscience, and Dextra Laboratories.
Key Companies to Watch
Merck KGaA
Overview: The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 57,000 employees and present in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences, and Electronics.
Product Portfolio: Glycosidases, including endoglycosidases and exoglycosidases, are primarily used in glycomics research for the sequencing of glycans, the release of N- and O-linked glycans from glycoproteins, and glycoprotein production. Glycosidases such as our recombinant Peptide-N-glycosidase F, PNGase Fast (EMS0001), enable complete and rapid deglycosylation of antibodies and immunoglobulin fusion proteins, as well as other glycoproteins, to be prepared for downstream chromatography or mass spectrometry analysis.
Frequently Asked Questions
What is the Projected CAGR value of the Glycomics and Glycobiology Market?
Glycomics and Glycobiology Market is expected to grow at a CAGR of 17.3% during the forecasting period 2024-2031.
Which region controlled the global market during 2024-2031?
North America region Controls the Glycomics and Glycobiology Market during 2024-2031
Which is the fastest growing region in the Glycomics and Glycobiology Market?
Among all regions, Asia Pacific is the fastest growing market share during the forecast period